Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Citrus Oil Formula May Relieve Dry Mouth for Cancer Patients
SATURDAY, March 29, 2025 -- A new formula made with natural citrus oil could help cancer patients find relief from dry mouth, a common and painful side effect...
Utah Becomes First State to Ban Community Water Fluoridation
FRIDAY, March 28, 2025 -- With a new law, signed by Gov. Spencer Cox on March 27, Utah has become the first U.S. state to ban the addition of fluoride to...
Combination Lipid-Lowering Therapy Linked to Greater Drop in LDL-C
FRIDAY, March 28, 2025 -- Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C)...
Many Women Undergo Annual Mammography, Despite Biennial Screening Recommendations
FRIDAY, March 28, 2025 -- A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening...
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
FRIDAY, March 28, 2025 -- For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is associated with...
Consensus Guidance Lays Out Recommendations for Postpartum Physical Activity
FRIDAY, March 28, 2025 -- New mothers are encouraged to engage in two hours per week of exercise, according to a consensus guideline published online March 25...
ACC: Bilateral Oophorectomy Linked to Increased Risk for Heart Failure
FRIDAY, March 28, 2025 -- Bilateral oophorectomy is associated with an increased risk for heart failure, with a greater risk seen with younger age and for...
Organ Transplant Patient Dies After Contracting Rabies
FRIDAY, March 28, 2025 -- A Michigan resident has died after receiving an organ transplant infected with rabies, state health officials said Wednesday. The...
Measles Outbreak Leads to Dangerous Vitamin A Toxicity
FRIDAY, March 28, 2025 -- As a measles outbreak spreads across U.S., doctors are now seeing a new and unexpected danger: Children getting sick from taking too...
Trump Administration To Cut 10,000 Health and Human Services Jobs
FRIDAY, March 28, 2025 -- The Trump administration will lay off 10,000 workers at the U.S. Department of Health and Human Services (HHS) as part of a major...
FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With or Without Inhibitors
Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine...
FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder Cancer
On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment...
FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan)...
FDA Approves Bomyntra (denosumab-bnht), a Biosimilar to Xgeva
LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilar Bomyntra (denosumab-bnht) of...
FDA Approves Conexxence (denosumab-bnht), a Biosimilar to Prolia
LAKE ZURICH, Ill., March 27, 2025 -- Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilar Conexxence (denosumab-bnht)...
FDA Grants Priority Review for Biologics License Application (BLA) for Apitegromab as a Treatment for Spinal Muscular Atrophy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 25, 2025-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative...
Tolebrutinib Regulatory Submission Accepted for Priority Review in the US for Patients with Multiple Sclerosis
Paris, March 25, 2025. The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat...
Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...
Depemokimab Applications Accepted for Review by the US FDA for Asthma with Type 2 Inflammation and for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
London, UK -- 03 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License...
FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar. 3, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and...
Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) Keytruda® (pembrolizumab) in Pivotal 3475A-D77 Trial
RAHWAY, N.J.--(BUSINESS WIRE) March 27, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first data...
Chlamydia Vaccine Candidate Granted Fast Track Designation by the US FDA
Paris, March 26, 2025. The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of...
Palatin’s Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency
CRANBURY, N.J., March 25, 2025 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
The United Laboratories and Novo Nordisk Announce Exclusive License Agreement for UBT251, a GLP-1/GIP/Glucagon Triple Receptor Agonist
Guangdong, China and Bagsværd, Denmark, 24 March 2025 –The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo...
NIH Researchers Develop Eye Drops That Slow Vision Loss in Animals
Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a group of inherited diseases that lead...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.